BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 4018277)

  • 1. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
    Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
    Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
    Custo GM; Carenza L; Pala A
    Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary-ovarian function after tubal ligation.
    Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A
    Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chorionic gonadotropin in women fitted with intrauterine device.
    Yarkoni S; Zer TA; Schenker JG
    Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin in intrauterine device users.
    Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
    Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative prolactin profiles in IUD users and non-IUD users.
    Adejuwon CA; Segal SJ; Faundes A; Alvarez-Sanchez F
    Contraception; 1982 Jun; 25(6):613-8. PubMed ID: 7116848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of serum steroid hormones in intrauterine contraceptive device users.
    Fahmy K; el-Gazar A; Eisa I; Ghonaim M; Saad S; Afifi A
    Gynecol Endocrinol; 1991 Mar; 5(1):1-5. PubMed ID: 1897380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
    Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
    Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian function during use of a levonorgestrel-releasing IUD.
    Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
    Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.